EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Immune cell transcriptional profiles from pre-vaccination peripheral blood predict immune response to preventative MUC1 cancer vaccine

Daniel Y Yuan, Michelle L McKeague, Vineet K Raghu, Robert E Schoen, Olivera J Finn, Panayiotis V Benos

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115685 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Daniel Y Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Joint Carnegie Mellon - University…. Hauptthemen laut MEDLINE: Cancer Vaccines, Mucin-1, Leukocytes, Mononuclear, Transcriptome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute, National Institutes of Health, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Recent advances in vaccine technology raise hopes for effective cancer preventative vaccines. The first clinical trials (single-arm NCT007773097; double-blind, placebo controlled randomized trial NCT02134925) of a non-viral cancer preventative vaccine were conducted in individuals with previous advanced colonic adenoma to test the safety and immunogenicity of the MUC1 tumor antigen vaccine. The vaccine was safe and strongly immunogenic in 43 %-25 % of participants. The lack of response in a significant number of participants suggested that the pre-malignant immune system may have already been exposed to some level of suppression, something previously reported only in cancer. METHODS: Single-cell RNA-sequencing (scRNA-seq) data were collected from banked pre-vaccination peripheral blood mononuclear cells (PBMCs) (16 immune responders and 16 non-responders) and analyzed using standard bioinformatic and novel machine learning methods. RESULTS: We identified specific cell types, genes, and pathways characteristic of vaccine response. A significantly higher percentage of CD4 + naïve T cells and lower percentage of CD8 + T effector memory (TEM) cells and CD16 + monocytes were present in responders. Differential gene expression (DGE) and transcription factor inference analysis showed a higher level of expression of T cell activation genes (like Fos, Jun) in CD4 + naïve T cells. Pathway analysis showed enriched signaling activity in responders. Furthermore, Bayesian graph analysis suggested that these genes were mechanistically related to response. CONCLUSIONS: Our analyses identified several immune mechanisms and candidate biomarkers which can be further validated as predictors of immune responses to a preventative cancer vaccine. These could facilitate selection of individuals likely to benefit from a vaccine or be used in further research to improve vaccine responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesMucin-1Leukocytes, MononuclearTranscriptomeHumansFemaleMaleMiddle AgedAgedDouble-Blind Method

Stichwörter der Autor:innen

Cancer immunopreventionCancer vaccineSingle cell RNA-seq

Substanzen

Cancer VaccinesMucin-1MUC1 protein, human

Autor:innen und Institutionen

  • Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Joint Carnegie Mellon - University of Pittsburgh Computational Biology PhD Program, Pittsburgh, PA, USA.
  • Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA, USA.
  • Departments of Medicine and Epidemiology, Division of Gastroenterology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: ojfinn@pitt.edu.
  • Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Joint Carnegie Mellon - University of Pittsburgh Computational Biology PhD Program, Pittsburgh, PA, USA;…

Förderung

  • National Cancer Institute
  • National Institutes of Health
  • National Heart Lung and Blood Institute

Zitieren

APA

Yuan, D. Y., McKeague, M. L., Raghu, V. K., Schoen, R. E., Finn, O. J., & Benos, P. V. (2025). Immune cell transcriptional profiles from pre-vaccination peripheral blood predict immune response to preventative MUC1 cancer vaccine. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115685

Vancouver

Yuan DY, McKeague ML, Raghu VK, Schoen RE, Finn OJ, Benos PV. Immune cell transcriptional profiles from pre-vaccination peripheral blood predict immune response to preventative MUC1 cancer vaccine. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115685

BibTeX
@article{Yuan2025,
  author = {Yuan, Daniel Y and McKeague, Michelle L and Raghu, Vineet K and Schoen, Robert E and Finn, Olivera J and Benos, Panayiotis V},
  title = {Immune cell transcriptional profiles from pre-vaccination peripheral blood predict immune response to preventative MUC1 cancer vaccine},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115685}
}
Kostenlos starten →